Sweden's coronavirus strategy: The Public Health Agency and the sites of controversy
World Medical & Health Policy · 2022-09 · 14 (3) · 507-527
DOI: 10.1002/wmh3.449 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Medical & Health Policy, online erschienen am 03.06.2021. Verfasst von Arash Heydarian Pashakhanlou. Beteiligte Einrichtung: Department of Military Studies Swedish Defence University Stockholm Sweden. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
In contrast to the vast majority of Western countries, Sweden left large segments of the society open instead of imposing a lockdown to combat the spread of the coronavirus. As a result, the Swedish COVID‐19 measures, largely devised by its expert agency on health, garnered widespread international attention. Despite the global interest in the corona strategy of the Public Health Agency of Sweden (PHAS), there are currently no systematic studies on their COVID‐19 policy. The present investigation focuses on the controversies that have characterized PHAS' work with reference to risk assessments, facemasks, voluntarism, testing, and the protection of the elderly during the pandemic. Overall, this inquiry demonstrates that PHAS' risk assessments were initially overly optimistic and their facemask recommendations in conflict with large segments of the scientific community for an extensive period. Yet, their voluntary measures worked moderately well. In their testing, PHAS did not manage to deliver on their promises in time, whereas several measures implemented to protect the elderly were deemed inadequate and late.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Military Studies Swedish Defence University Stockholm Sweden.
ORCID-Profile: Arash Heydarian Pashakhanlou
Zitieren
APA
Pashakhanlou, A. H. (2022). Sweden's coronavirus strategy: The Public Health Agency and the sites of controversy. World Medical & Health Policy, 14(3), 507-527. https://doi.org/10.1002/wmh3.449
Vancouver
Pashakhanlou AH. Sweden's coronavirus strategy: The Public Health Agency and the sites of controversy. World Medical & Health Policy. 2022;14(3):507-527. doi:10.1002/wmh3.449
BibTeX
@article{Pashakhanlou2022,
author = {Pashakhanlou, Arash Heydarian},
title = {Sweden's coronavirus strategy: The Public Health Agency and the sites of controversy},
journal = {World Medical & Health Policy},
year = {2022},
volume = {14},
number = {3},
pages = {507--527},
doi = {10.1002/wmh3.449}
}
EUVIMED